These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 29914872)
1. Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer. Park S; Willingham MC; Qi J; Cheng SY Endocr Relat Cancer; 2018 Oct; 25(10):865-877. PubMed ID: 29914872 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model. Park JW; Han CR; Zhao L; Willingham MC; Cheng SY Endocr Relat Cancer; 2016 Jan; 23(1):53-63. PubMed ID: 26552408 [TBL] [Abstract][Full Text] [Related]
3. Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model. Kim WG; Park JW; Willingham MC; Cheng SY Endocrinology; 2013 Aug; 154(8):2936-47. PubMed ID: 23748362 [TBL] [Abstract][Full Text] [Related]
4. Metformin blocks progression of obesity-activated thyroid cancer in a mouse model. Park J; Kim WG; Zhao L; Enomoto K; Willingham M; Cheng SY Oncotarget; 2016 Jun; 7(23):34832-44. PubMed ID: 27145454 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model. Park JW; Zhao L; Willingham MC; Cheng SY Am J Cancer Res; 2017; 7(3):727-739. PubMed ID: 28401024 [TBL] [Abstract][Full Text] [Related]
6. SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model. Zhu X; Kim DW; Zhao L; Willingham MC; Cheng SY Endocr Relat Cancer; 2016 Jul; 23(7):521-33. PubMed ID: 27267120 [TBL] [Abstract][Full Text] [Related]
7. Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model. Zhu X; Enomoto K; Zhao L; Zhu YJ; Willingham MC; Meltzer P; Qi J; Cheng SY Clin Cancer Res; 2017 Jan; 23(2):430-440. PubMed ID: 27440272 [TBL] [Abstract][Full Text] [Related]
8. Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma. Lu C; Zhu X; Willingham MC; Cheng SY Oncogene; 2012 Apr; 31(16):2007-16. PubMed ID: 21909131 [TBL] [Abstract][Full Text] [Related]
9. Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer. Enomoto K; Zhu X; Park S; Zhao L; Zhu YJ; Willingham MC; Qi J; Copland JA; Meltzer P; Cheng SY J Clin Endocrinol Metab; 2017 Jul; 102(7):2268-2280. PubMed ID: 28368473 [TBL] [Abstract][Full Text] [Related]
10. Inflammation suppression prevents tumor cell proliferation in a mouse model of thyroid cancer. Park S; Kim M; Zhu J; Lee WK; Altan-Bonnet G; Meltzer P; Cheng SY Am J Cancer Res; 2020; 10(6):1857-1870. PubMed ID: 32642296 [TBL] [Abstract][Full Text] [Related]
11. Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer. Fozzatti L; Park JW; Zhao L; Willingham MC; Cheng SY PLoS One; 2013; 8(6):e67954. PubMed ID: 23840792 [TBL] [Abstract][Full Text] [Related]
12. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer. Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027 [TBL] [Abstract][Full Text] [Related]
13. BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells. Mio C; Conzatti K; Baldan F; Allegri L; Sponziello M; Rosignolo F; Russo D; Filetti S; Damante G Oncol Rep; 2018 Feb; 39(2):582-588. PubMed ID: 29251329 [TBL] [Abstract][Full Text] [Related]
14. Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor. Zhao L; Zhu X; Won Park J; Fozzatti L; Willingham M; Cheng SY Endocrinology; 2012 Oct; 153(10):5090-100. PubMed ID: 22919057 [TBL] [Abstract][Full Text] [Related]
15. SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer. Kim WG; Guigon CJ; Fozzatti L; Park JW; Lu C; Willingham MC; Cheng SY Clin Cancer Res; 2012 Mar; 18(5):1281-90. PubMed ID: 22271876 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer. Furuya F; Lu C; Willingham MC; Cheng SY Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507 [TBL] [Abstract][Full Text] [Related]
17. Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors. Guigon CJ; Kim DW; Willingham MC; Cheng SY Oncogene; 2011 Jul; 30(30):3381-90. PubMed ID: 21399657 [TBL] [Abstract][Full Text] [Related]
18. Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model. Park S; Zhu J; Altan-Bonnet G; Cheng SY Am J Cancer Res; 2019; 9(7):1439-1453. PubMed ID: 31392080 [TBL] [Abstract][Full Text] [Related]
19. Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation. Zhu X; Zhao L; Park JW; Willingham MC; Cheng SY Neoplasia; 2014 Sep; 16(9):757-69. PubMed ID: 25246276 [TBL] [Abstract][Full Text] [Related]
20. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer. Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]